137 related articles for article (PubMed ID: 31554366)
1. Stage-Specific Survival Rate of Breast Cancer Patients in Northern Thailand in Accordance with Two Different Staging Systems.
Chitapanarux I; Sripan P; Somwangprasert A; Charoentum C; Onchan W; Watcharachan K; Wongmaneerung P; Kongmebhol P; Jia-Mahasap B; Huntrakul L
Asian Pac J Cancer Prev; 2019 Sep; 20(9):2699-2706. PubMed ID: 31554366
[TBL] [Abstract][Full Text] [Related]
2. Validation of AJCC TNM staging for breast tumors diagnosed before 2004 in cancer registries.
Kwan ML; Haque R; Lee VS; Joanie Chung WL; Avila CC; Clancy HA; Quinn VP; Kushi LH
Cancer Causes Control; 2012 Sep; 23(9):1587-91. PubMed ID: 22798182
[TBL] [Abstract][Full Text] [Related]
3. Analysis of stage and clinical/prognostic factors for lung cancer from SEER registries: AJCC staging and collaborative stage data collection system.
Chen VW; Ruiz BA; Hsieh MC; Wu XC; Ries LA; Lewis DR
Cancer; 2014 Dec; 120 Suppl 23(0 0):3781-92. PubMed ID: 25412390
[TBL] [Abstract][Full Text] [Related]
4. Revisiting the AJCC staging system of adrenocortical carcinoma.
Abdel-Rahman O
J Endocrinol Invest; 2022 Jan; 45(1):89-94. PubMed ID: 34170487
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of the AJCC 8th edition staging system for selecting patients with T1-2N1 breast cancer for post-mastectomy radiotherapy: a joint analysis of 1986 patients from two institutions.
Wang S; Wen G; Tang Y; Yang Y; Jing H; Wang J; Zhang J; Zhao X; Sun G; Jin J; Song Y; Liu Y; Fang H; Zhang Y; Li Y
BMC Cancer; 2020 Aug; 20(1):792. PubMed ID: 32838753
[TBL] [Abstract][Full Text] [Related]
6. Effect of Incorporation of Pretreatment Serum Carcinoembryonic Antigen Levels Into AJCC Staging for Colon Cancer on 5-Year Survival.
Thirunavukarasu P; Talati C; Munjal S; Attwood K; Edge SB; Francescutti V
JAMA Surg; 2015 Aug; 150(8):747-755. PubMed ID: 26083632
[TBL] [Abstract][Full Text] [Related]
7. Validation of the 8th AJCC prognostic staging system for breast cancer in a population-based setting.
Abdel-Rahman O
Breast Cancer Res Treat; 2018 Feb; 168(1):269-275. PubMed ID: 29143220
[TBL] [Abstract][Full Text] [Related]
8. Rethinking the Current American Joint Committee on Cancer TNM Staging System for Medullary Thyroid Cancer.
Adam MA; Thomas S; Roman SA; Hyslop T; Sosa JA
JAMA Surg; 2017 Sep; 152(9):869-876. PubMed ID: 28636692
[TBL] [Abstract][Full Text] [Related]
9. Revisiting Dukes' paradigm; some node positive colon cancer patients have better prognosis than some node negative patients.
Abdel-Rahman O
Clin Transl Oncol; 2018 Jun; 20(6):794-800. PubMed ID: 29086248
[TBL] [Abstract][Full Text] [Related]
10. Assessing a modified-AJCC TNM staging system in the New South Wales Cancer Registry, Australia.
Lawrance S; Bui C; Mahindra V; Arcorace M; Cooke-Yarborough C
BMC Cancer; 2019 Aug; 19(1):850. PubMed ID: 31462255
[TBL] [Abstract][Full Text] [Related]
11. Assessment of the prognostic and discriminating value of the novel bioscore system for breast cancer; a SEER database analysis.
Abdel-Rahman O
Breast Cancer Res Treat; 2017 Jul; 164(1):231-236. PubMed ID: 28417332
[TBL] [Abstract][Full Text] [Related]
12. Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging.
O'Connell JB; Maggard MA; Ko CY
J Natl Cancer Inst; 2004 Oct; 96(19):1420-5. PubMed ID: 15467030
[TBL] [Abstract][Full Text] [Related]
13. The assessment of 8th edition AJCC prognostic staging system and a simplified staging system for breast cancer: The analytic results from the SEER database.
Zhang J; Zhao B; Jin F
Breast J; 2019 Sep; 25(5):838-847. PubMed ID: 31192530
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the 8th edition of the American joint committee on cancer's pathological staging system in prognosis assessment and treatment decision making for stage T1-2N1 breast cancer after mastectomy.
Wu SG; Wang J; Lian CL; Lei J; Hua L; Lin Q; Chen YX; He ZY
Breast; 2020 Jun; 51():2-10. PubMed ID: 32172191
[TBL] [Abstract][Full Text] [Related]
15. The Prognostic Value of the 8th Edition of the American Joint Committee on Cancer (AJCC) Staging System in HER2-Enriched Subtype Breast Cancer, a Retrospective Analysis.
Zhou B; Xu L; Ye J; Xin L; Duan X; Liu Y
Anticancer Res; 2017 Aug; 37(8):4615-4621. PubMed ID: 28739761
[TBL] [Abstract][Full Text] [Related]
16. Site-specific factors for cancer of the corpus uteri from SEER registries: collaborative stage data collection system, version 1 and version 2.
Jamison PM; Altekruse SF; Chang JT; Zahn J; Lee R; Noone AM; Barroilhet L
Cancer; 2014 Dec; 120 Suppl 23():3836-45. PubMed ID: 25412395
[TBL] [Abstract][Full Text] [Related]
17. Modified the 8th AJCC staging system for patients with advanced prostate cancer: a study based on SEER database.
Sun C; Yang D; Zhu J; Zhou Y; Xiang C; Wu S
BMC Urol; 2022 Nov; 22(1):185. PubMed ID: 36384495
[TBL] [Abstract][Full Text] [Related]
18. Triple-negative breast cancer has worse overall survival and cause-specific survival than non-triple-negative breast cancer.
Li X; Yang J; Peng L; Sahin AA; Huo L; Ward KC; O'Regan R; Torres MA; Meisel JL
Breast Cancer Res Treat; 2017 Jan; 161(2):279-287. PubMed ID: 27888421
[TBL] [Abstract][Full Text] [Related]
19. Metastatic breast cancer survival improvement restricted by regional disparity: Surveillance, Epidemiology, and End Results and institutional analysis: 1990 to 2011.
Malmgren JA; Calip GS; Atwood MK; Mayer M; Kaplan HG
Cancer; 2020 Jan; 126(2):390-399. PubMed ID: 31639221
[TBL] [Abstract][Full Text] [Related]
20. Reassessment of the current American Joint Committee on Cancer staging system for pancreatic neuroendocrine tumors.
Qadan M; Ma Y; Visser BC; Kunz PL; Fisher GA; Norton JA; Poultsides GA
J Am Coll Surg; 2014 Feb; 218(2):188-95. PubMed ID: 24321190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
